Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Workman

Showing results (181-190 of 315) with videos related to

Pageof 32
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 11, 2005
3-(5-Chloro-2,4-dihydroxyphenyl)-pyrazole-4-carboxamides as inhibitors of the Hsp90 molecular chaperonePaul A Brough, Xavier Barril, Mandy Beswick, et al.
Gynecologic Oncology|December 22, 2007
Opportunities and challenges in ovarian cancer research, a perspective from the 11th Ovarian cancer action/HHMT Forum, Lake Como, March 2007Alan Ashworth, Frances Balkwill, Robert C Bast, et al.
Oncotarget|June 19, 2017
Pediatric and adult glioblastoma radiosensitization induced by PI3K/mTOR inhibition causes early metabolic alterations detected by nuclear magnetic resonance spectroscopyAlice Agliano, Geetha Balarajah, Daniela M Ciobota, et al.
Molecular Cancer Therapeutics|July 5, 2006
Preclinical pharmacokinetics and metabolism of a novel diaryl pyrazole resorcinol series of heat shock protein 90 inhibitorsNicola F Smith, Angela Hayes, Karen James, et al.
Molecular Cancer Therapeutics|March 17, 2007
A duplexed phenotypic screen for the simultaneous detection of inhibitors of the molecular chaperone heat shock protein 90 and modulators of cellular acetylationAnthea Hardcastle, Peter Tomlin, Clair Norris, et al.
ACS Chemical Biology|February 25, 2009
Structural basis of the radicicol resistance displayed by a fungal hsp90Chrisostomos Prodromou, James M Nuttall, Stefan H Millson, et al.
Scientific Reports|September 30, 2020
Solution structure of the Hop TPR2A domain and investigation of target druggability by NMR, biochemical and in silico approachesJohn F Darby, Lewis R Vidler, Peter J Simpson, et al.
Journal of Biomolecular Screening|July 29, 2010
Identification by high-throughput screening of viridin analogs as biochemical and cell-based inhibitors of the cell cycle-regulated nek2 kinaseDaniel G Hayward, Yvette Newbatt, Lisa Pickard, et al.
Molecular Cancer Therapeutics|January 25, 2006
Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cellsMounia Beloueche-Babari, L Elizabeth Jackson, Nada M S Al-Saffar, et al.
Molecular Cancer Therapeutics|November 16, 2004
Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: antisense down-regulation of exon 5 alters target gene expression and inhibits cell survivalJane Renshaw, Rosanne M Orr, Michael I Walton, et al.
Pageof 32

Showing results (181-190 of 315) with videos related to

Sort By:
Pageof 32
Bioorganic & Medicinal Chemistry Letters|October 11, 2005
3-(5-Chloro-2,4-dihydroxyphenyl)-pyrazole-4-carboxamides as inhibitors of the Hsp90 molecular chaperonePaul A Brough, Xavier Barril, Mandy Beswick, et al.
Gynecologic Oncology|December 22, 2007
Opportunities and challenges in ovarian cancer research, a perspective from the 11th Ovarian cancer action/HHMT Forum, Lake Como, March 2007Alan Ashworth, Frances Balkwill, Robert C Bast, et al.
Oncotarget|June 19, 2017
Pediatric and adult glioblastoma radiosensitization induced by PI3K/mTOR inhibition causes early metabolic alterations detected by nuclear magnetic resonance spectroscopyAlice Agliano, Geetha Balarajah, Daniela M Ciobota, et al.
Molecular Cancer Therapeutics|July 5, 2006
Preclinical pharmacokinetics and metabolism of a novel diaryl pyrazole resorcinol series of heat shock protein 90 inhibitorsNicola F Smith, Angela Hayes, Karen James, et al.
Molecular Cancer Therapeutics|March 17, 2007
A duplexed phenotypic screen for the simultaneous detection of inhibitors of the molecular chaperone heat shock protein 90 and modulators of cellular acetylationAnthea Hardcastle, Peter Tomlin, Clair Norris, et al.
ACS Chemical Biology|February 25, 2009
Structural basis of the radicicol resistance displayed by a fungal hsp90Chrisostomos Prodromou, James M Nuttall, Stefan H Millson, et al.
Scientific Reports|September 30, 2020
Solution structure of the Hop TPR2A domain and investigation of target druggability by NMR, biochemical and in silico approachesJohn F Darby, Lewis R Vidler, Peter J Simpson, et al.
Journal of Biomolecular Screening|July 29, 2010
Identification by high-throughput screening of viridin analogs as biochemical and cell-based inhibitors of the cell cycle-regulated nek2 kinaseDaniel G Hayward, Yvette Newbatt, Lisa Pickard, et al.
Molecular Cancer Therapeutics|January 25, 2006
Identification of magnetic resonance detectable metabolic changes associated with inhibition of phosphoinositide 3-kinase signaling in human breast cancer cellsMounia Beloueche-Babari, L Elizabeth Jackson, Nada M S Al-Saffar, et al.
Molecular Cancer Therapeutics|November 16, 2004
Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: antisense down-regulation of exon 5 alters target gene expression and inhibits cell survivalJane Renshaw, Rosanne M Orr, Michael I Walton, et al.
Pageof 32